PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Excessive release of neutrophil extracellular traps (NETs) has been implicated in several organ fibrosis, including pulmonary fibrosis. NETs constitute a phenomenon in which decorated nuclear chromatin with cytosolic proteins is released into the extracellular space. PAD4 (peptidylarginine deiminase 4) plays an important role in the formation of NETs. However, the role of NETs in the pathogenesis of pulmonary fibrosis remains undefined. Here, we identified NETs in the alveolar and interstitial lung space of mice undergoing bleomycin (BLM)-induced lung fibrosis, which was suppressed by a pan-PAD inhibitor, Cl-amidine. In vitro, BLM directly induced NETs in blood neutrophils, which was also inhibited by Cl-amidine. Furthermore, Padi4 gene knockout (PAD4-KO) in mice led to the alleviation of BLM-induced NETs and pulmonary fibrosis and to the expression of inflammatory and fibrotic genes. PAD4 deficiency prevented decreases in alveolar epithelial and pulmonary vascular endothelial cell numbers and increases in ACTA2-positive mesenchymal cells and S100A4-positive fibroblasts in the lung. Hematopoietic cell grafts from PAD4-KO mice, not wild-type mice, resolved BLM-induced lung fibrosis and fibrotic gene expression in wild-type and PAD4-KO mice, suggesting that expression of PAD4 in hematopoietic cells may be involved in the development of lung fibrosis. These data suggest that PAD4 deficiency could ameliorate BLM-induced formation of NETs and lung fibrosis, suggesting that this pathway could serve as a therapeutic target for pulmonary fibrosis treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stiff substrates promote increased neutrophil spreading, ROS production, and the release of neutrophil extracellular traps (NETs), a process termed NETosis (95,96).”
From The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives (2025) · doi:10.3389/fimmu.2025.1670213 · cites this paper as [100]
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Novel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
Papayannopoulos, V., Metzler, K. D., Hakkim, A., & Zychlinsky, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201006052 · Cited by 2,103
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Saffarzadeh, M., Juenemann, C., Queisser, M. A., Lochnit, G., Barreto, G., Galuska, S. P., Lohmeyer, J., & Preissner, K. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032366 · Cited by 1,335
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Warnatsch, A., Ioannou, M., Wang, Q., & Papayannopoulos, V. (2015) · Science · doi:10.1126/science.aaa8064 · Cited by 1,270
Cited by
Neutrophil extracellular traps in homeostasis and disease
Wang, H., Kim, S. J., Lei, Y., Wang, S., Wang, H., Huang, H., Zhang, H., & Tsung, A. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01933-x · Cited by 537
NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond
Zhu, Y., Chen, X., & Liu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.838011 · Cited by 172
Zhang, H., Wu, D., Wang, Y., Guo, K., Spencer, C. B., Ortoga, L., Qu, M., Shi, Y., Shao, Y., Wang, Z., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1389 · Cited by 143
Immune mechanisms in fibrotic interstitial lung disease
Kamiya, M., Carter, H. M., Espíndola, M. S., Doyle, T. J., Lee, J. S., Merriam, L. T., Zhang, F., Kawano-Dourado, L. B., Sparks, J. A., Hogaboam, C. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.015 · Cited by 141
Ahangari, F., Becker, C., Foster, D. G., Chioccioli, M., Nelson, M., Beke, K. M., Wang, X., Justet, A., Adams, T. S., Readhead, B. P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3832oc · Cited by 124
Wang, Z., Liu, J., Li, F., Luo, Y., Ge, P., Zhang, Y., Wen, H., Yang, Q., Ma, S., & Chen, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106321 · Cited by 107
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease
Liang, W., Yang, Y., Gong, S., Wei, M., Ma, Y., Feng, R., Gao, J., Liu, X., Tu, F., Ma, W., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.018 · Cited by 107
Abaricia, J. O., Shah, A. H., & Olivares-Navarrete, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120715 · Cited by 86
Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease
Santacroce, G., Lenti, M. V., & Sabatino, A. D. (2022) · Cells · doi:10.3390/cells11030429 · Cited by 86
Neutrophil extracellular traps and pulmonary fibrosis: an update
Yan, S., Li, M., Liu, B., Ma, Z., & Yang, Q. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00329-y · Cited by 77
“Pretreatment of neutrophils with Cl-amidine, a PAD4 inhibitor that inhibits NETs release by blocking guanylation of histone H3 and subsequent incubation with cigarette smoke extract inhibited the differentiation and activation of fibroblasts [53].”
BackgroundTrivedi, A., Khan, M. A., Bade, G., & Talwar, A. (2021) · Biomedicines · doi:10.3390/biomedicines9010053 · Cited by 74
Gao, F., Peng, H., Gou, R., Zhou, Y., Ren, S., & Li, F. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00670-3 · Cited by 77
Role and intervention of PAD4 in NETs in acute respiratory distress syndrome
Liu, X., Li, T., Chen, H., Li, Y., & Ao, H. (2024) · Respiratory Research · doi:10.1186/s12931-024-02676-7 · Cited by 62
“Studies have shown that inhibition of PAD4 activity can inhibit the formation of NETs in mice and humans (Table 1) [77].”
BackgroundNeutrophil Extracellular Traps in Airway Diseases: Pathological Roles and Therapeutic Implications
Jo, A., & Kim, D. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055034 · Cited by 64
The Mechanisms of Sepsis Induced Coagulation Dysfunction and Its Treatment
Zhu, L., Dong, H., Li, L., & Liu, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s504184 · Cited by 70
“143,144 Another therapeutic strategy involves Toll-like receptor (TLR) inhibitors.”
Pratt, H. G., Steinberger, K. J., Mihalik, N. E., Ott, S., Whalley, T., Szomolay, B., Boone, B. A., & Eubank, T. D. (2021) · Cancers · doi:10.3390/cancers14010194 · Cited by 60
“versible chronic scarring in sporadic regions of the lungs, rich in collagen deposition [171].”
BackgroundAhmad, R. S., Eubank, T. D., Łukomski, S., & Boone, B. A. (2021) · Biomolecules · doi:10.3390/biom11060901 · Cited by 62
Update in Interstitial Lung Disease 2020
Podolanczuk, A. J., Wong, A. W., Saito, S., Lasky, J. A., Ryerson, C. J., & Eickelberg, O. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202103-0559up · Cited by 68
The Dynamic Contribution of Neutrophils in the Chronic Respiratory Diseases
Ham, J., Kim, J., Ko, Y. G., & Kim, H. Y. (2022) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2022.14.4.361 · Cited by 56
Role of gut microbes in acute lung injury/acute respiratory distress syndrome
Ren, Z., Zheng, Z., & Feng, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2440125 · Cited by 48
Negreros, M., & Flores-Suárez, L. F. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102781 · Cited by 48
Neutrophil extracellular traps in tumor progression and immunotherapy
Yan, M., Gu, Y., Sun, H., & Ge, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135086 · Cited by 55
“Various stimuli trigger NET formation, such as lipopolysaccharides (LPS), phorbol 12-myristate 13-acetate (PMA) (5), high mobility group box 1 [HMGB1] (21), tumor-associated stimuli (tumor-associated antigen, granulocyte-colony stimulating factor [G-CSF] (22), C-X-C motif chemokine ligands [CXCLs] (23), cathepsin C (2…”
BackgroundZohny, M. H., Cavalu, S. D., Youssef, M. E., Kaddah, M. M. Y., Mourad, A. A. E., Gaafar, A. G. A., El-Ahwany, E. G., Amin, N. A., Arakeep, H. M., Shata, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112723 · Cited by 47
Neutrophil extracellular traps and long COVID
Shafqat, A., Omer, M. H., Albalkhi, I., Razzak, G. A., Abdulkader, H. S., Rab, S. A., Sabbah, B. N., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1254310 · Cited by 53
Diesler, R., & Cottin, V. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2089116 · Cited by 43
“Furthermore, PADI deficiency and inhibition of citrullination improves bleomycin-induced pulmonary fibrosis in a mouse model [50].”
BackgroundNeutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives
Crowley, L., Stockley, R. A., THICKETT, D. R., Dosanjh, D. P. S., Scott, A., & Parekh, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0139-2024 · Cited by 56
Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury
Liu, T., Yang, Q., Zheng, H., Jia, H., He, Y., Zhang, X., Zheng, J., Xi, Y., Zhang, H., Sun, R., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121103 · Cited by 40
PM2.5 Exposure Induces Lung Injury and Fibrosis by Regulating Ferroptosis via TGF-β Signaling
Guo, L. Y., Bai, S., Ding, S., Zhao, L., Xu, S., & Wang, X. (2022) · Disease Markers · doi:10.1155/2022/7098463 · Cited by 43
“The recently approved treatments for pulmonary fibrosis, such as nintedanib and pirfenidone, are indicated to repress the event of lung dysfunction [4, 5].”
BackgroundRetractedIGF2BP2: an m6A reader that affects cellular function and disease progression
Liu, S., Liao, S., He, J., Zhou, Y., & He, Q. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00723-9 · Cited by 52
“In addition to phagocytosis and degranulation, neutrophils can also release neutrophil extracellular traps (NETs)— DNA material webs decorated with bactericidal proteins—effectively trapping microorganisms in circulation [34].”
Benzyl butyl phthalate (BBP) induces lung injury and fibrosis through neutrophil extracellular traps
Wang, W., Liu, Z., Zhang, Y., Wang, L., Meng, D., Li, X., Zhang, J., Wu, Y., Zhou, X., & Liu, G. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119743 · Cited by 42
Who and how, DNA sensors in NETs-driven inflammation
Aubé, F.-A., Bidias, A. R., & Pépin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190177 · Cited by 38
“In pre-clinical models, accumulating evidence suggests that preventing NETs formation using inhibitor of PAD4 for example (45, 63) could benefit patients.”
BackgroundLung regeneration: diverse cell types and the therapeutic potential
Chen, Y., Li, Z., Ji, G., Wang, S., Mo, C., & Ding, B. (2024) · MedComm · doi:10.1002/mco2.494 · Cited by 39
Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27
Riehl, D., Sharma, A., Roewe, J., Murke, F., Ruppert, C., Eming, S. A., Bopp, T., Kleinert, H., Radsak, M. P., Colucci, G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215421120 · Cited by 34
“NETs and externalized histones are involved in the pathophysiology of acute lung injury (15, 17, 18), sepsis (14), infection (19, 20), autoimmune disease (21), thrombosis (16, 22), and pulmonary fibrosis (23, 24).”
Nets in fibrosis: Bridging innate immunity and tissue remodeling
Ma, X., Ji-pin, L., Li, M., Qi, G., Wei, L., & Zhang, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112516 · Cited by 33
Neutrophil extracellular traps in tumor metabolism and microenvironment
Liu, Z., Dou, Y., Lu, C., Han, R., & He, Y. (2025) · Biomarker Research · doi:10.1186/s40364-025-00731-z · Cited by 40
“Cl-amidine, an experimental drug, inhibits the formation of NETs by irreversibly inhibiting the activity of PAD4 enzyme [175–178].”
Role of Neutrophils on the Ocular Surface
Mun, Y., Hwang, J. S., & Shin, Y. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910386 · Cited by 37
“PAD4 inhibitor block neutrophil extracellular trap formation [46], reducing bleomycin fibrosis [47,48].”
BackgroundNeutrophil Extracellular Traps and Respiratory Disease
King, P. T., & Dousha, L. F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082390 · Cited by 37
“PAD4 knockout mice (which do not make NETs) have fewer active fibroblasts and ILD [142].”
BackgroundHiroki, C. H., Hassanabad, M. F., Defaye, M., Sarden, N., Bartlett, A., Farias, R., Nguyen, A., Guerrero-Fonseca, I. M., Yoon, G., Brown, L., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.05.002 · Cited by 37
Fang, X., Ma, L., Wang, Y., Ren, F., Yu, Y., Yuan, Z., Wei, H., Zhang, H., & Sun, Y. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003231 · Cited by 32
“Proteins involved in NETs formation, such as peptidyl arginine deiminase 4 (PAD4), can cause fibrosis [21].”
Background(2025) · doi:10.3389/fimmu.2025.1670213 · Cited by 29
Recent advances in the role of neutrophils and neutrophil extracellular traps in acute pancreatitis
Ishqi, H. M., Ali, M., & Dawra, R. K. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01180-4 · Cited by 32
“They also contribute to tissue remodelling [40], cystic fibrosis [110] and organ fibrosis including myocardial [111] and pulmonary fibrosis [112].”
Gu, X., Kang, H., Cao, S., Tong, Z., & Song, N. (2025) · Translational Research · doi:10.1016/j.trsl.2024.10.002 · Cited by 28
d’Alessandro, M., Conticini, E., Bergantini, L., Cameli, P., Cantarini, L., Frediani, B., & Bargagli, E. (2022) · Life · doi:10.3390/life12020317 · Cited by 30
“Recently, Suzuki and colleagues identified NETs in the alveolar and interstitial lung space of mice undergoing bleomycin-induced lung fibrosis, which was suppressed by a pan-PAD inhibitor, demonstrating that Padi4 gene knockout in mice led to the alleviation of bleomycin-induced NETs and pulmonary fibrosis; this findi…”
BackgroundImmune cells crosstalk Pathways, and metabolic alterations in Idiopathic pulmonary fibrosis
Tiwari, P., Verma, S., Washimkar, K. R., & Mugale, M. N. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112269 · Cited by 33
Transcriptomic and Proteomic Changes Driving Pulmonary Fibrosis Resolution in Young and Old Mice
Weckerle, J., Mayr, C. H., Fundel‐Clemens, K., Lämmle, B., Boryń, Ł. M., Thomas, M. J., Bretschneider, T., Luippold, A. H., Huber, H. J., Viollet, C., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0012oc · Cited by 27
Hook, J. S., Patel, P. A., O’Malley, A., Xie, L., Kavanaugh, J. S., Horswill, A. R., & Moreland, J. G. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100283 · Cited by 29
Adel, R. M., Helal, H., Fouad, M. A., & Abd-Elhalem, S. S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111456 · Cited by 29
Extracellular traps and the role in thrombosis
Han, T., Tang, H., Lin, C., Shen, Y., Dong, Y., Tang, X., & Guo, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.951670 · Cited by 23
“Cl-amidine effectively blocked the synthesis of NETs based on its irreversible blocking properties in both in vitro neutrophils and murine lupus models in vivo (163, 166, 167), and disease severity was effectively attenuated in mouse models of various diseases, such as cardiovascular events (166), sepsis (168), and co…”
BackgroundRecent Insights into Neutrophil Extracellular Traps in Cardiovascular Diseases
Dong, Y., Zhang, Y., Yang, X., Yan, C., & Feng, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226662 · Cited by 24
“In PAD4-deficient mice, bleomycin-induced NET production and its associated pulmonary inflammation and fibrosis were significantly reduced [18].”
BackgroundMa, W., Zhu, J., Bai, L., Zhao, P., Li, F., & Zhang, S. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad059 · Cited by 25
Zhu, D., Yu, L., Hu, B., Pang, Y., Liu, B., Zhang, M., Wang, W., & Wang, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115619 · Cited by 25
Aji, N., Wang, L., Wang, S., Pan, T., Song, J., Chen, C., Wang, L., Feng, N., Tang, X., & Song, Y. (2024) · Inflammation · doi:10.1007/s10753-024-02102-6 · Cited by 20
“It is difficult to observe the complete structure of webs or other shapes in injured lung tissue, which may be limited by the lung parenchyma space [34].”
Palko, S. I., Saba, N. J., Bargagna‐Mohan, P., & Mohan, R. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25158 · Cited by 19
“One key player in the perpetuation of scarring in AMD may be glial cells, as they contribute to scarring via chronic gliosis (Telegina et al., 2018).”
BackgroundChen, M., Li, L., Chai, Y., Yang, Y., Ma, S., Pu, X., & Chen, Y. (2023) · Medicine · doi:10.1097/md.0000000000033417 · Cited by 19
“[53] In addition, NETs can also promote fibroblast proliferation and migration and induce the conversion of fibroblasts to myofibroblast phenotype by upregulating the expression of CTGF, promoting collagen production, and ultimately aggravating tissue fibrosis[54] (Fig.”
BackgroundNeutrophil extracellular traps (NETs) and fibrotic diseases
Wu, X., & Yang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112085 · Cited by 20
Lu, Z., Zhu, L., Yi, C., Su, B., & Wang, R. (2025) · Annals of Medicine · doi:10.1080/07853890.2024.2447406 · Cited by 17
Erosive arthritis autoantibodies in systemic sclerosis
Riccardi, A., Martinroche, G., Contin‐Bordes, C., Avouac, J., Chenevier‐Gobeaux, C., Cauvet, A., Guerini, H., Truchetet, M., & Allanore, Y. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.11.013 · Cited by 17
Neutrophil extracellular traps and neutrophilic asthma
Xiang, J., Cui, M., & Zhang, Y. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108150 · Cited by 17
Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
Kooistra, E. J., Dahm, K., van Herwaarden, A. E., Gerretsen, J., Nuesch-Germano, M., Mauer, K., Smeets, R. L., van der Velde, S., van den Berg, M. J. W., van der Hoeven, J. G., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02496-1 · Cited by 18
“Interestingly, the release of NETs has been shown to play a role in the development of organ fibrosis [23] and their release is dependent on histone modification by peptidylarginine deiminase 4 (PADI4) [23, 24], which was one of the top 10 genes in the lightgreen module (Fig.”
BackgroundQi, M.-Z., Huang, H., Li, Z., Quan, J., Wang, J., Huang, F., Zhang, X., Chen, P., 刘安, Gao, Z., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156147 · Cited by 17
Wang, S., Xu, D., Wang, Y., Zhou, Y., Xiao, L., Li, F., Tu, J., Qin, W., Tian, S., Zheng, B., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0903 · Cited by 15
Wu, T., Zhang, Y., Cen, Z., Ying, Y., Sun, C., Lv, C., & Ding, Q. (2022) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666221140974 · Cited by 14
Dragoni, G., Ke, B.-J., Picariello, L., Abdurahiman, S., Ceni, E., Biscu, F., Mello, T., Polvani, S., Innocenti, T., Spalart, V., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae121 · Cited by 18
Cao, W., Huang, L., Yu, H., Qian, Y., Liu, L., Xu, M., Li, S., Zhou, H., & Li, F. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119391 · Cited by 16
Panda, B., Momin, A., Devabattula, G., Chilvery, S., Sharma, A., & Godugu, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112861 · Cited by 13
Lei, L., Liu, J., Li, Y., Huang, B., & Zou, Z. (2026) · iScience · doi:10.1016/j.isci.2026.115585 · Cited by 14
Chen, Z., Shi, Q., Liu, X., Lu, G., Yang, J., Luo, W., & Yang, F. (2024) · Pharmacology · doi:10.1159/000538490 · Cited by 14
Holthaus, M., Xiong, X., Eghbalzadeh, K., Großmann, C., Geißen, S., Piontek, F., Mollenhauer, M., Abdallah, A. T., Kamphausen, T., Rothschild, M. A., et al. (2025) · Translational research · doi:10.1016/j.trsl.2025.04.003 · Cited by 13
Therapeutic use of calpeptin in COVID-19 infection
Inal, J. M., Paizuldaeva, A., & Terziu, E. (2022) · Clinical Science · doi:10.1042/cs20220638 · Cited by 9
Akboua, H., Eghbalzadeh, K., Keser, U., Wahlers, T., & Paunel‐Görgülü, A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16915 · Cited by 12
Li, K., Liu, P., Zhang, W., Liu, X., Tanino, Y., Koga, Y., & Yan, X. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3700 · Cited by 12
“Thus, PADI4 deficiency can ameliorate bleomycin-induced NET formation and pulmonary fibrosis (28).”
BackgroundRethinking neutrophil extracellular traps
Liu, Y., Ma, Y.-H., Yang, J.-W., Man, J.-W., Wang, H.-B., Li, Y., Liang, C., Cao, J., Chen, S., Li, K.-P., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110834 · Cited by 14
Nava-Quiroz, K. J., López-Flores, L. A., Pérez-Rubio, G., Rojas‐Serrano, J., & Falfán‐Valencia, R. (2023) · Cells · doi:10.3390/cells12242829 · Cited by 13
Potential Role of Neutrophil Extracellular Traps in Cardio-Oncology
Cheng, K., Contreras, G. P., & Yeh, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073573 · Cited by 12
“There are several possible candidates for mitigating NETs burden, including potent anti-platelet therapy to inhibit platelet activation, deoxyribonuclease (DNase I) to break down circulating free DNA, the inhibition of peptidyl arginine deiminase-4 (PAD4) to form NETs, and the inhibition of MPO and anti-cytokine thera…”
BackgroundInfluentialWang, M., Zhao, H., Zhao, H., Huo, C., Yu, Y., & Zhu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23633 · Cited by 9
“This reagent can block histone 3 citrullination and the formation of NETs, so the Cl-amidine group was used as a positive control group in this experiment [15].”
MethodRole of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs
Yu, F., Chen, J., Zhang, X., Ma, Z., Wang, J., & Wu, Q. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14942 · Cited by 9
Panda, B., Chilvery, S., Devi, P., Kalmegh, R., & Godugu, C. (2025) · Life Sciences · doi:10.1016/j.lfs.2024.123354 · Cited by 10
Citrullination of matrisomal proteins in health and diseases
Saifi, M. A., & Ho, I. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0244 · Cited by 10
Sun, J., Wang, G., Wang, H., Hua, F., Song, Z., Jin, Z., Liu, J., Xin, H., & Zhang, M. (2022) · NPG Asia Materials · doi:10.1038/s41427-021-00352-6 · Cited by 9
Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survivalPreprint
Matson, S. M., Ngo, L. T., Sugawara, Y., Fernando, V., Lugo, C., Azeem, I., Harrison, A., Alsup, A., Nissen, E., Koestler, D. C., et al. (2024) · medRxiv · doi:10.1101/2024.01.24.24301742 · Cited by 9
“Additionally, in mouse models, inhibition of NETosis reduces bleomycin-induced lung injury [25].”
Liu, R., Liu, H., Yang, L., Li, C., Yin, G., & Xie, Q. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01384-2 · Cited by 8
Katsumata, M., Ikari, J., Urano, A., Suzuki, E., Kugou, K., Hasegawa, Y., Tatsumi, K., & Suzuki, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125573 · Cited by 9
“Collectively, these data suggest that PAD4-dependent NET formation is a significant contributor to the pathogenesis of lung fibrosis [18].”
InfluentialSelf-citationYu, F., Li, S., Li, B., Zhan, P., Wang, X., & Yang, J. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118325 · Cited by 10
Chen, Z.-M., He, J.-H., Tang, R., Yue, J.-Q., Zhang, X.-X., He, Z.-F., Li, S.-Q., Li, H.-M., Zhang, X.-F., Cen, L.-J., et al. (2025) · Research · doi:10.34133/research.0958 · Cited by 13
“In support of our findings, PAD4 knockout significantly mitigated NET formation in a bleomycin-induced fibrosis mouse model [ 49 ], suggesting that PAD4 represents a promising therapeutic target for chronic neutrophilic airway diseases.”
High-dose vitamin C attenuates radiation-induced pulmonary fibrosis by targeting S100A8 and S100A9
Ma, L., Jin, Y., Aili, A., Xu, L., Wang, X., Xiao, L., Zhao, W., Yin, S., Liu, B., & Yuan, X. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167358 · Cited by 8
Li, K., Jiang, K.-M., Wang, Y., Hu, F., Zhu, X.-C., Sun, C.-L., Jin, L., Lin, T., Lin, T.-T., & Li, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114016 · Cited by 7
Liu, L., Lan, Z., Liu, X., Chen, Y., Chen, Z., Cheng, L., & Hu, T. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05375-z · Cited by 11
“In contrast, the addition of Cl-amidine treatment further decreased the formation of NETs, which is consistent with previous studies [39, 40].”
Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications
Liang, X., Li, Y., Tang, Z., Luo, Y., & Liu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718092 · Cited by 8
Gao, J., Zhang, Z., Yu, J., Zhang, N., Fu, Y., Jiang, X., Xia, Z., Zhang, Q., & Wen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s444774 · Cited by 9
“68,69 Our transcriptome analysis revealed a significant increase in PADI4 expression, particularly in patients with PGD 2 grade or more, and the upregulation of PADI4 may contribute to the elevated NET formation.”
BackgroundAripova, N., Duryee, M. J., Zhou, W., England, B. R., Hunter, C. D., Klingemann, L. E., Aripova, N., Nelson, A. J., Katafiasz, D. M., Bailey, K. L., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00153.2024 · Cited by 7
Ma, C., Dai, Y., Qin, W., Han, W., Wang, X., & Sun, L. (2025) · European journal of medical research · doi:10.1186/s40001-025-02544-0 · Cited by 6
“Furthermore, PAD4 has been shown to promote the formation of NETs and aggravate damage to the alveolar epithelium and endothelial cells both in vivo and in vitro [26].”
Meng, X., Li, J., Lu, Q., Zhang, J., Zheng, Y., Liu, Z., Ji, M., Kou, Z., Li, L., & Fan, H. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117149 · Cited by 6
Src Reduces Neutrophil Extracellular Traps Generation and Resolves Acute Organ Damage
Lu, G., Han, F., Wang, Y., Yuan, C., Zhu, Q., Xia, T., Chen, L., Dong, X., Ding, Y., Xiao, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202506028 · Cited by 10
The Roles of Neutrophil Cells in the Pathogenesis of Fibrosis: Mechanisms for Disease Progression
Zheng, Y., Xu, H., Guo, M., Yu, Y., & Wang, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501715r · Cited by 7
“NETs contribute to alveolar epithelial and endothelial injury in a concentration-dependent manner through the cytotoxic effects of released histones [99, 130], exacerbating early inflammation and promoting the recruitment and activation of myofibroblasts [95].”
Guardians Turned Culprits: NETosis and Its Influence on Pulmonary Fibrosis Development
Varughese, A., Balnadupete, A., Ramesh, P., Prasad, T. S. K., Nidha, A. B., & Bhandary, Y. P. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01171-0 · Cited by 8
“It contributes to the formation of NETs [31, 68].”
Du, Y., Shuai, R., Luo, S., Jin, Y., Xu, F., Zhang, J., Liu, D., & Feng, L. (2024) · Biology Direct · doi:10.1186/s13062-024-00583-x · Cited by 10
Alekseeva, L. A., Васильевна, С. А., Sounbuli, K., Savin, I. A., Аркадьевна, З. М., & Mironova, N. L. (2025) · Biomolecules · doi:10.3390/biom15020298 · Cited by 6
Yan, C., Zhang, Y., Jin, L., Liu, X., Zhu, X., Li, Q., Wang, Y., Hu, L., He, X., Bao, H., et al. (2024) · Journal of Biomedical Research · doi:10.7555/jbr.38.20240038 · Cited by 5
Perioperative NETosis and Cancer Progression: Current Evidence and Future Perspectives
Zhang, Q., Zhang, J., Gu, H., Yang, Y., Zhang, H., & Miao, C. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01573-y · Cited by 7
“Many drugs, such as DNase I [49, 50], PAD4 inhibitors [51, 52], NE inhibitors [53], and cathepsin C(CTSC) [54] are a commonly used to inhibit NETs formation.”
A GPVI-platelet-neutrophil-NET axis drives systemic sclerosisPreprint
Darbousset, R., Villanueva-Martín, G., Kuehn, J., Navarro, S., Balu, S., Miglani, D., Dillon, E., Fromson, C., Senkpeil, L., Elahee, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.21.634123 · Cited by 7
Metadata
- Authors
- Suzuki, M., Ikari, J., Anazawa, R., Tanaka, N., Katsumata, Y., Shimada, A., Suzuki, E., & Tatsumi, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Ikari, Jun
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-01
- Volume
- 63
- Issue
- 6
- Pages
- 806-818
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W3085038700
- Cited by
- 143
- References
- 50
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 28 · 2023: 21 · 2022: 20 · 2021: 11
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- PAD4, neutrophil extracellular traps, pulmonary fibrosis, bleomycin-induced lung injury, Cl-amidine, hematopoietic cells, alveolar epithelial cells, pulmonary endothelial cells, fibroblasts, mesenchymal cells, S100A4, ACTA2, therapeutic target
- MeSH terms
- Protein-Arginine Deiminase Type 4, Animals, Bleomycin, Disease Models, Animal, Fibrosis, Lung, Male, Mice, Inbred C57BL, Neutrophils, Pulmonary Fibrosis, Mice, Knockout, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.